REG-Tetragon Financial Group Ltd: Statement re: Monthly Factsheet

Tetragon FinancialAnnouncement

30/11/2022 07:15

Tetragon Financial Group Limited October 2022 Monthly Factsheet

LONDON, Nov. 30, 2022 /PRNewswire/ -- Tetragon has released its Monthly
Factsheet for October 2022.
* Net Asset Value: $2,679m
* Fully Diluted NAV Per Share: $28.33
* Share Price (TFG NA): $9.46
* Monthly NAV per share total return: 0.8%
* Monthly Return on Equity: 0.9%
* Most recent quarterly dividend: $0.11
* Dividend yield: 4.7%
Please refer to important disclosures on page three of the Monthly Factsheet.

Please click below to access the Monthly Factsheet.

October 2022 Factsheet 
(https://c212.net/c/link/?t=0&l=en&o=3722037-1&h=2674867582&u=https%3A%2F%2Fwww.tetragoninv.com%2F%7E%2Fmedia%2FFiles%2FT%2FTetragon-V2%2Ffinancial-report%2F2022%2Fmonthly-factsheet-oct-2022.pdf&a=October+2022+Factsheet%C2%A0)

About Tetragon:

Tetragon is a closed-ended investment company that invests in a broad range of
assets, including public and private equities and credit (including distressed
securities and structured credit), convertible bonds, real estate, venture
capital, infrastructure, bank loans and TFG Asset Management, a diversified
alternative asset management business. Where appropriate, through TFG Asset
Management, Tetragon seeks to own all, or a portion, of asset management
companies with which it invests in order to enhance the returns achieved on
its capital. Tetragon's investment objective is to generate distributable
income and capital appreciation. It aims to provide stable returns to
investors across various credit, equity, interest rate, inflation and real
estate cycles. The company's non-voting shares are traded on Euronext in
Amsterdam, a regulated market of Euronext Amsterdam N.V., and on the
Specialist Fund Segment of the main market of the London Stock Exchange. For
more information please visit the company's website at www.tetragoninv.com.

 Tetragon:  Yuko Thomas Investor Relations ir@tetragoninv.com  Press Inquiries:  Prosek Partners Pro-tetragon@prosek.com  United States Ryan FitzGibbon Remy Marin +1 646 818 9298 +1 646 818 9234  United Kingdom Henrietta Dehn Alexa Bethell +44 7717 281 665 +44 7940 166 251  

This release does not contain or constitute an offer to sell or a
solicitation of an offer to purchase securities in the United States or any
other jurisdiction. The securities of Tetragon have not been and will not be
registered under the U.S. Securities Act of 1933 and may not be offered or
sold in the United States or to U.S. persons unless they are registered under
applicable law or exempt from registration. Tetragon does not intend to
register any portion of its securities in the United States or to conduct a
public offer of securities in the United States. In addition, Tetragon has not
been and will not be registered under the U.S. Investment Company Act of 1940,
and investors will not be entitled to the benefits of such Act. Tetragon is
registered in the public register of the Netherlands Authority for the
Financial Markets under Section 1:107 of the Financial Markets Supervision Act
as a collective investment scheme from a designated country.     



Copyright (c) 2022 PR Newswire Association,LLC. All Rights Reserved